The AIDS Beacon » Treatments

HIV Drug Interactions

Kieryn Graham — Tue, 14 Dec 2010 22:56:34 +0000

HIV-druginteractions.org provides up-to-date, comprehensive, and reliable information about interactions between anti-HIV drugs and other drugs. It also features HIV-related articles which are updated on a regular basis.

Department of Health and Human Services (HHS) – AIDSinfo

Shruti Kalra — Thu, 13 Aug 2009 02:14:39 +0000

AIDSinfo is a website maintained by the U.S. Department of Health and Human Services (HHS). Its purpose is to bring federal information regarding HIV and AIDS research, treatments, prevention, and medical practices to the public. This website specifically focuses on clinical research information and medical guidelines as related to the care of people with HIV and AIDS.

zidovudine: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:12:00 +0000

Zidovudine (Retrovir) belongs to class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Zidovudine exists as a syrup and a tablet and can also be administered intravenously. Zidovudine is an ingredient in Combivir (zidovudine/lamivudine) and Trizivir (zidovudine/lamivudine/abacavir).

Ziagen: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:11:08 +0000

Ziagen (abacavir) belongs to class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Ziagen is taken in tablet form, and can be prescribed in either a once daily or twice daily dosage.

Selzentry.com: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:10:08 +0000

Selzentry (maraviroc) is a CCR5-blocking entry inhibitor, which means that it binds to a protein on the membrane of CD4 cells (white blood cells) called CCR5. Once it does this, HIV cannot successfully attach itself to the surface of CD4 cells, and is prevented from infecting healthy cells. Selzentry is not recommended for people under 16 years of age. Some patients taking Selzentry have experienced serious side effects, including liver problems.

Viread: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:08:01 +0000

Viread (tenofovir) belongs to class of anti-HIV drugs known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself.

Viramune.com: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:06:09 +0000

Viramune (nevirapine) belongs to a class of anti-HIV drugs known as non-nucleoside reverse transcriptase inhibitors, which bind to and block the action of reverse transcriptase, an essential protein that HIV needs in order to replicate. Some people taking Viramune have experienced serious side effects, such as severe liver disease or skin reactions.

Viracept: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:04:07 +0000

Viracept (nelfinavir) belongs to a class of anti-HIV drugs known as protease inhibitors, which are known to reduce the amount of HIV in the blood and to increase the number of CD4 cells in the body.

Truvada: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 02:02:50 +0000

Truvada (emtricitabine/tenofovir) is a combination pill containing two anti-HIV drugs in the class known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Truvada is taken once a day.

Trizivir: Information for Patients

Shruti Kalra — Thu, 13 Aug 2009 01:54:56 +0000

Trizivir (zidovudine/lamivudine/abacavir) is a combination pill containing three anti-HIV drugs in the class known as nucleoside reverse transcriptase inhibitors (NRTIs). NRTIs act as fake versions of the building blocks HIV needs, preventing HIV from making copies of itself. Trizivir is taken twice daily.